BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• XPhyto Completes Rotigotine Transdermal Patch Optimization and Comparative Skin Absorption Study

  XPhyto Therapeutics Corp. is pleased to provide a product development report on its Rotigotine transdermal patch.

  October 11, 2022

   · 

  5 min read
• Business

  Compass Therapeutics Announces Clinical Collaboration with Merck to Evaluate CTX-471 in Combination with KEYTRUDA® (pembrolizumab)

  Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today announced a clinical trial collaboration and supply agreement with Merck (known as MSD outside the United States and Canada).

  October 11, 2022

   · 

  5 min read
• Business

  aTyr Pharma Announces Research Collaboration with Dualsystems Biotech AG to Identify 10 New Therapeutic Targets

  aTyr Pharma, Inc. today announced that it has entered into a research collaboration with Dualsystems Biotech AG, a company specializing in custom proteomics, aimed at accelerating drug discovery and generating new therapeutics based on aTyr’s extensive intellectual property.

  October 11, 2022

   · 

  6 min read
• Business

  Tarsus Announces Transition Plans for Board of Directors

  Tarsus Pharmaceuticals, Inc., whose mission is to address patient needs, starting with eye care, through the application of proven science and new technology, announced several expected upcoming transitions to its Board of Directors by year-end.

  October 11, 2022

   · 

  5 min read